Felicia Ruffin

Dr. Felicia Ruffin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JPJoshua Parsons
Joshua Parsons
ASAshelyn E. Sidders
Ashelyn E. Sidders
AVAmanda Z. Velez
Amanda Z. Velez
BHBlake M. Hanson
Blake M. Hanson
MAMichelle Angeles-Solano
Michelle Angeles-Solano
BCBrian P. Conlon
Brian P. Conlon
Gram-negative bacterial bloodstream infections (GNB-BSI) are common and frequently lethal. Despite appropriate antibiotic treatment, relapse of GNB-BSI with the same bacterial strain is common and associated with poor clinical outcomes and high healthcare costs. The role of persister cells, which are sub-populations of bacteria that survive for prolonged periods in the presence of bactericidal antibiotics, in relapse of GNB-BSI is unclear. Using a cohort of patients with relapsed GNB-BSI, we aimed to determine how the pathogen evolves within the patient between the initial and subsequent episodes of GNB-BSI and how these changes impact persistence. Using Escherichia coli clinical bloodstream isolate pairs (initial and relapse isolates) from patients with relapsed GNB-BSI, we found that 4/11 (36%) of the relapse isolates displayed a significant increase in persisters cells relative to the initial bloodstream infection isolate. In the relapsed E. coli strain with the greatest increase in persisters (100-fold relative to initial isolate), we determined that the increase was due to a loss-of-function mutation in the ptsI gene encoding Enzyme I of the phosphoenolpyruvate phosphotransferase system. The ptsI mutant was equally virulent in a murine bacteremia infection model but exhibited 10-fold increased survival to antibiotic treatment. This work addresses the controversy regarding the clinical relevance of persister formation by providing compelling data that not only do high-persister mutations arise during bloodstream infection in humans but also that these mutants display increased survival to antibiotic challenge in vivo.

15 March 2022 in iScience
Verified
Journal Article
Open access
JXJoao B. Xavier
Joao B. Xavier
JMJonathan Monk
Jonathan Monk
SPSaugat Poudel
Saugat Poudel
CNCharles J. Norsigian
Charles J. Norsigian
ASAnand V. Sastry
Anand V. Sastry
MYMichael R. Yeaman
Michael R. Yeaman
Mathematical models have many applications in infectious diseases: epidemiologists use them to forecast outbreaks and design containment strategies; systems biologists use them to study complex processes sustaining pathogens, from the metabolic networks empowering microbial cells to ecological networks in the microbiome that protects its host. Here, we (1) review important models relevant to infectious diseases, (2) draw parallels among models ranging widely in scale. We end by discussing a minimal set of information for a model to promote its use by others and to enable predictions that help us better fight pathogens and the diseases they cause.

8 December 2022 in Nursing Open
Verified
Journal Article
Open access
FRFelicia Ruffin
Felicia Ruffin
EHElizabeth Van Horn
Elizabeth Van Horn
SLSusan Letvak
Susan Letvak
LKLaurie Kennedy‐Malone
Laurie Kennedy‐Malone
AimWe explored patient pre-hospital delays in seeking care for symptoms of bacteremia and sepsis. DesignA qualitative descriptive study. MethodsIn January 2021, we recruited a convenience sample of four men and six women who were former patients diagnosed with bacteremia. We conducted semi-structured interviews by telephone. The tape-recorded interviews were transcribed, coded and analysed using the Common-Sense Model of Self-Regulation. Data analysis continued until May 2021. ResultsThe three main themes included: gathering threads of information, weaving together the threads of information and impact and outcome of the illness. The main finding revealed was that an inability to recognize symptoms of bacteremia resulted in delayed help-seeking. Participants had difficulty recognizing their symptoms as being related to bacteremia when they lacked experience with infection or could not differentiate them from symptoms of other chronic co-morbid conditions. Recognizing symptoms and searching for their meaning was an early step in developing an action plan for seeking care. Patient-reported physical and psychological outcomes of the infection on their quality of life (QOL) varied widely, from none to major impact.

26 August 2023 in Nursing Open
Verified
Journal Article
Open access
FRFelicia Ruffin
Felicia Ruffin
EHElizabeth Van Horn
Elizabeth Van Horn
LKLaurie Kennedy‐Malone
Laurie Kennedy‐Malone
SLSusan Letvak
Susan Letvak
Aim: Research suggests that early access to quality care is essential to improving bacteraemia outcomes and reducing the risk of developing sepsis because it allows for early intervention. Currently, there are limited data regarding the facilitators and barriers that alter the trajectory of arrival at the hospital when patients in the United States experience symptoms of bacteraemia and sepsis. This study sought to explore and describe the facilitators and barriers to seeking care for suspected bacteraemia and sepsis symptoms.Design: A qualitative descriptive study.Methods: Ten men and women were recruited using convenience sampling. The study used audio‐recorded semi‐structured interviews and the collection of socio‐demographic data as the data collection techniques. Thematic analysis was used, including inductive and deductive approaches, to analyse the data.Results: During data analysis, the codes related to barriers and facilitators were collapsed into three themes—symptom recognition, psychosocial support and healthcare planning and coordination.Patient Contribution: The patients' participation in the study has contributed to our understanding of patients' perspectives and experiences in the pre‐hospital phase and provides important insights into what barriers and facilitators are encountered. Study findings highlight the need to develop interventions to improve patient decision time, patient–provider interactions and knowledge of bacteraemia and sepsis through patient and provider education.

27 January 2026 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WWWenliang Wang
Wenliang Wang
MHManoj Hariharan
Manoj Hariharan
WDWubin Ding
Wubin Ding
ABAnna Bartlett
Anna Bartlett
CBCesar Barragan
Cesar Barragan
JEJoseph R. Ecker
Joseph R. Ecker
The epigenome of human immune cells is shaped by both genetics and environmental factors, yet the relative contributions of these influences remain incompletely characterized. Here we use single-nucleus methylation sequencing and assay for transposase-accessible chromatin using sequencing (ATAC–seq) to systematically explore how pathogen and chemical exposures, along with genetic variation, are associated with changes in the immune cell epigenome. Distinct exposure-associated differentially methylated regions (eDMRs) and differentially accessible regions were identified, and a significant correlation between these two modalities was observed. Additionally, genotype-associated DMRs (gDMRs) were detected, indicating that eDMRs are enriched in regulatory regions, whereas gDMRs are preferentially located within gene body marks. Disease-associated single-nucleotide polymorphisms were frequently colocalized with methylation quantitative trait loci, providing cell-type-specific insights into the genetic basis of diseases. These findings highlight the complex interplay between genetic and environmental factors in shaping the immune cell epigenome and advance understanding of immune cell regulation in health and disease.

30 April 2024 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
JCJackson L Chin
Jackson L Chin
ZTZhixin Cyrillus Tan
Zhixin Cyrillus Tan
LCLiana Chan
Liana Chan
FRFelicia Ruffin
Felicia Ruffin
RPRajesh Parmar
Rajesh Parmar
YZYing Zheng
Ying Zheng
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is a common and life-threatening infection that imposes up to 30% mortality even when appropriate therapy is used. Despite in vitro efficacy determined by minimum inhibitory concentration breakpoints, antibiotics often fail to resolve these infections in vivo, resulting in persistent MRSA bacteremia. Recently, several genetic, epigenetic, and proteomic correlates of persistent outcomes have been identified. However, the extent to which single variables or their composite patterns operate as independent predictors of outcome or reflect shared underlying mechanisms of persistence is unknown. To explore this question, we employed a tensor-based integration of host transcriptional and cytokine datasets across a well-characterized cohort of patients with persistent or resolving MRSA bacteremia outcomes. This method yielded high correlative accuracy with outcomes and immunologic signatures united by transcriptomic and cytokine datasets. Results reveal that patients with persistent MRSA bacteremia (PB) exhibit signals of granulocyte dysfunction, suppressed antigen presentation, and deviated lymphocyte polarization. In contrast, patients with resolving bacteremia (RB) heterogeneously exhibit correlates of robust antigen-presenting cell trafficking and enhanced neutrophil maturation corresponding to appropriate T lymphocyte polarization and B lymphocyte response. These results suggest that transcriptional and cytokine correlates of PB vs. RB outcomes are complex and may not be disclosed by conventional modeling. In this respect, a tensor-based integration approach may help to reveal consensus molecular and cellular mechanisms and their biological interpretation.